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International Classification of Diseases the 10th Revision (ICD-10) was implemented 
October 1, 2015, and there was little knowledge how the transition to ICD-10 would 
impact the revenue cycle for intraoperative neurophysiological monitoring medical 
practices in Oklahoma.  This correlational quantitative study examined the changes in 
dependent variables of reimbursements due to the change from ICD-9 to ICD-10 for 
independent variables of intraoperative neurophysiological monitoring procedure codes.  
The reimbursements from 2014 were compared to reimbursements from 2016.  Prices 
were adjusted for inflation to 2016 dollar values.  Annual reimbursements decreased for 
all intraoperative neurophysiological monitoring procedures examined except the remote 
monitoring code.  The intraoperative neurophysiological monitoring procedure with the 
greatest mean annual decreases in reimbursement was the lower somatosensory evoked 
potentials.  The intraoperative neurophysiological monitoring procedures with the least 
annual reimbursement decreases were transcranial electrical motor potential monitoring 
and electromyography.  The findings of the budget-impact analysis and cost-effectiveness 
analysis indicated that reimbursement for procedures has steadily decreased from 2014 to 
2016, causing a negative effect on practices’ revenue cycle management.  The findings of 
this study could benefit intraoperative neurophysiological monitoring companies in 
Oklahoma by supporting adjustments essential for healthcare leaders to maintain a 
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Section 1: Foundation of the Study and Literature Review  
Introduction 
The changes in medical coding from International Classification of Diseases 
(ICD) 9th to the 10th revision was a massive undertaking by physicians, hospitals, and 
clinics.  The positive and negative effects of this change have been uncovered for 
specialties across the United States.  This study will evaluate the changes in 
reimbursements due to the change from ICD-9 to ICD-10 for intraoperative 
neurophysiological monitoring in Oklahoma.  There are several small intraoperative 
neurophysiological monitoring companies in Oklahoma and these changes may affect 
their livelihood.  Without a study on the changes in reimbursement, these companies 
could cease to be financially solvent.  The potential positive social change implications of 
the study will assist healthcare leadership to understand these changes to be able to make 
the necessary changes in business.  It could also assist their revenue cycle management to 
ensure the stability and future of Oklahoma intraoperative neurophysiological monitoring 
companies.  This section will cover the background, purpose, theoretical framework of 
the problem, and research questions. 
Background 
Knowledge regarding the business effects of reimbursement changes is 
fundamental for any healthcare organization.  Without effective leadership, healthcare 
organizations can experience difficulty establishing processes to stay compliant and 
profitable (Colton & Wofford, 2013).  
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Rethinking revenue cycle management by understanding financial implications 
will allow intraoperative neurophysiological monitoring leadership to ensure competitive 
advantage and to grow (Hackbarth & Gamble, 2017).  Revenue cycle management 
includes an office’s medical claims processing, payments, and revenue generation.  The 
office processes patient eligibility, collection of copays, claims coding, claims tracking, 
payment collection, and follow-up of denied claims (Bentley & Robinson, 2016).  Loss of 
revenue and reimbursements occurs through inappropriate use of ICD-10.   
Data analytics, contract management, coding, and denial of claims management 
represent key pieces of the revenue cycle management for a practice manager’s review 
(Cerner, 2017).  The concepts of business operations and implementation best practices 
can be lost, which affect the financial viability of the practice.  This is because providers 
are too busy with patient care as they focus on clinical aspects instead of management 
(Healthcare Financial Management Association [HFMA], 2015).   
Padarthy (2012) described the conversion of code sets as touching every aspect of 
the practice from patient care to data analysis.  The conversion from ICD-9 to ICD-10 
affects every part of healthcare business requiring an analysis to determine the overall 
effects.  A financial impact analysis will assess the changes in reimbursement.  The 
changes in reimbursements caused by the change from ICD-9 to ICD-10 must be studied 
to ensure the financial stability of the practice and specialty.  
The estimated time and cost of the revenue cycle for an inpatient surgical 
procedure is 100 minutes with reimbursement of $215.10 per procedure, which accounts 
for 3.1% of total revenues (Tseng, Kaplan, Richman, Shah, & Schulman, 2018).  With 
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administrative costs estimated at 25-31% of total health care expenditures in the United 
States (Tseng et al., 2018), an understanding of the changes in reimbursements will 
enable intraoperative neurophysiological monitoring company leaders to optimize 
revenues.  The financial benefits of an effective revenue cycle management process 
comprise a linear relationship between the measurement of the effectiveness with positive 
outcomes (Singh, Mindel, & Mathiassen, 2017).   Practice leaders need to understand the 
revenue and reimbursement requirements to effectively make decisions for the company 
(Fang & Li, 2015).  The ICD-10 implementation affected everyone and all resources 
within a health system (Leenheer, 2012).  Since the implementation of ICD-10 on 
October 1, 2015, I did not find literature regarding the effect to the revenue cycle for 
intraoperative neurophysiological monitoring.   
Problem Statement 
When ICD10 was implemented, there was little knowledge of how that transition 
would impact the revenue cycle for intraoperative neurophysiological monitoring medical 
practices in Oklahoma.  The increased costs of implementing the ICD-10-CM were not 
studied previously to determine the effect on reimbursement rates for intraoperative 
neurophysiological monitoring medical practices in Oklahoma for healthcare leadership.  
Knowledge of the reimbursement changes and the effects on the business are 
fundamental for any healthcare organization to survive and to thrive in the market.   
Without effective healthcare leadership, the organizations will have a difficult 
time establishing the required processes to stay compliant and profitable (Colton & 
Wofford, 2013).  The intraoperative neurophysiological monitoring industry constantly 
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changes with new companies as well as acquisitions in the area and surrounding states 
such as the NuVasive, Inc. acquisition of NeuroNetwork, LLC for 98 million dollars (PR, 
2017).  The intraoperative neurophysiological monitoring market is expected to reach 
$3.6 billion by 2025, which caused intraoperative neurophysiological monitoring 
acceptance as a standard of care due to its benefits (PR, 2017).  More research about the 
importance of accurate use was needed for healthcare administrators’ use in 
intraoperative neurophysiological monitoring.  The literature contains information on 
revenue cycle management, but it does not include specific information on intraoperative 
neurophysiological monitoring other than a few blogs. 
Purpose 
The purpose of this correlational, quantitative study was to provide understanding 
specific for health care leaders regarding the changes in reimbursement following ICD-10 
implementation in intraoperative neurophysiological monitoring companies in Oklahoma.  
In this project I addressed the lack of research specific to the administrative side of 
intraoperative neurophysiological monitoring.  The results of this study may provide 
much-needed insights into the actual changes that affects this industry allowing 
healthcare revenue cycle managers and management to adjust business practices to stay 
profitable.  There is a gap in studies on the changes in reimbursement following ICD-10 
implementation in most specialties, especially intraoperative neurophysiological 
monitoring companies.  The variables that will be studied will be the Current Procedural 
Terminology (CPT) codes for intraoperative neurophysiological monitoring and the 
reimbursements for each code specific to a variety of insurance companies, such as 
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Medicare, Medicaid, and average of commercial insurance carriers following the ICD-10 
implementation years.  The relationship between the CPT code and the reimbursement 
amount centers on payment differences to physicians and other providers who earn their 
income based on the services they provide (CPT) and were paid by insurance companies 
(reimbursements) based on the CPT codes performed and submitted. The ICD-10 coding 
is the major change in coding for the diagnosis or the reason for the CPT/procedure. The 
specification requirements for ICD-10 determine whether documentation by providers 
meets guidelines of payment codes. The physicians’ in specialties such as orthopedics 
were at risk of losing revenue due to poor documentation (Lussier et al., 2016).  This 
research may provide information for leadership to use for a better understanding of the 
effect of changes in reimbursements following ICD-10 implementation for intraoperative 
neurophysiological monitoring. 
Research Questions and Hypothesis 
The overarching research question is: What is the statistical significance, if any, 
between the changes in reimbursements from following the ICD-10 implementation in 
intraoperative neurophysiological monitoring companies in Oklahoma?  The datasets will 
provide the reimbursements per CPT code for 2014 and 2016 to include before ICD-10 
implementation and following.  The CPT codes for the study are listed below in addition 
to the research questions.  I included Medicare, Medicaid, and other commercial 





CPT Codes for Intraoperative Neurophysiological Monitoring 
CPT Code Description 
G0453 Remote Intraoperative Monitoring  
95925 Upper SSEP Bilateral 
95926 Lower SSEP Bilateral 
95938 Upper & Lower SSEP Bilateral 
95927 Trunk/Head SSEP Bilateral 
95928 TcMEP Upper Limbs 
95939 TcMEP Upper & Lower Limbs 
95937 NeuroMusclular Junction (TOF) 
95861 EMG Two Extremity 
95870 Trunk/Extremity EMG 
51785 Anal Sphincter 
95812 EEG 41-60 minutes 
95813 EEG greater than 1 hour 
 
Research Question1: To what extent was the difference, if any, between the 
independent variables of intraoperative neurophysiological monitoring CPT codes and 
dependent continuous variables within the Medicare Fee Schedule for 2014 and 2016 for 
intraoperative neurophysiological monitoring companies in Oklahoma? 
H01: There was not a statistically significant difference on independent variables 
of intraoperative neurophysiological monitoring CPT codes and dependent continuous 
variables of the Medicare Fee Schedule for 2014 and 2016. 
Ha1: There was a statistically significant difference on independent variables of 
intraoperative neurophysiological monitoring CPT codes and dependent continuous 
variables of the Medicare Fee Schedule for 2014 and 2016. 
Research Question 2: What was the difference between the independent variables 
of intraoperative neurophysiological monitoring CPT codes and the dependent 
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continuous variables of the rate paid by commercial carriers for 2014 and 2016 for 
intraoperative neurophysiological monitoring companies in Oklahoma? 
H02: There was not a statistically significant difference between the independent 
variables of intraoperative neurophysiological monitoring CPT codes and dependent 
continuous variables of the rate paid by commercial carriers for 2014 and 2016. 
Ha2: There was a statistically significant difference between the independent 
variables of intraoperative neurophysiological monitoring CPT codes and dependent 
continuous variables of the rate paid by commercial carriers for 2014 and 2016. 
Research Question 3: How did the conversion from ICD-9 to ICD-10 (i.e., 2014 
versus 2016) affect the revenue cycle management for intraoperative neurophysiological 
monitoring companies in Oklahoma? 
H03: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) positively 
affected the revenue cycle management for intraoperative neurophysiological monitoring 
companies in Oklahoma.  
Ha3: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) negatively 
affected the revenue cycle management for intraoperative neurophysiological monitoring 
companies in Oklahoma. 
Theoretical Foundation 
The theoretical base or conceptual framework that grounded the study is budget 
impact analysis and cost-effectiveness analysis.  The changes in reimbursements for 
intraoperative neurophysiological monitoring requires a broad view of budget impact 
analysis and cost-effectiveness analysis for the effects on short-term and long-term 
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practice management and revenue cycle management considerations (Bilinski et al., 
2017).   Cost-effectiveness and budget impact analysis will enable practice managers to 
design the revenue cycle department for intraoperative neuromonitoring companies to be 
successful and closes the gap between cost-effectiveness and affordability (Bilinski et al., 
2017).  Cutler and Ericson (2010) used cost-effectiveness analysis with the social cost 
and posted prices in the pharmaceutical industry. 
Nature of the Study 
The nature of the study will be a quantitative research approach, which is 
appropriate for the topic identified in the problem statement of reimbursement rates in 
intraoperative neurophysiological monitoring.  The independent variables of 
intraoperative neurophysiological monitoring CPT codes will be compared to the 
dependent variables of insurance reimbursements and the Medicare Fee Schedule for the 
year 2014 and 2016 through statistical testing of sample t test.  
The variances in reimbursement for the CPT codes used in intraoperative 
neurophysiological monitoring from 2014 to 2016 will be analyzed, which is the period 
of the conversion from ICD-9 to ICD-10.  To account for the possible yearly inflation 
allowed in the codes, a review of the allowable codes from each year will be used for 
comparison regarding what was paid and compared to the percentage of Medicare rates. 
Literature Search Strategy 
The literature review integrated comprehensive research on the topics of 
intraoperative neurophysiological monitoring and reimbursements.  Various search 
methods were used on medical association websites, medical affiliated organizations 
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websites, government websites, and primary source reports.  Peer-reviewed literature, 
studies, and dissertations were retrieved from Walden University’s online library system, 
Google Scholar, PubMed, Medline, Proquest, and EBSCOHost using the keywords: 
intraoperative neurophysiological monitoring with revenue, reimbursements, practice 
management, revenue cycle management, cash flow, financials, revenue stream, ICD-10, 
medical billing, and coding.  The search resulted in a limited number of scholarly 
references on the specific area of study of intraoperative neurophysiological monitoring 
and administrative terms.  Research on intraoperative neurophysiological monitoring was 
found, but nothing on the administration (nonclinical) aspect.  Research is available on 
ICD-10 implantation terms such as revenue cycle management, revenue stream and 
finance but not within the past 5 years.  ICD-10 was announced by the United States 
Department of Health and Human Services on July 31, 2014, that ICD-10-CM and ICD-
10-PCS will be implemented into the HIPAA mandated code set on Oct 1, 2015 
(Nicoletti, 2014).  The literature examined provided a knowledge base for the study.  
Change in Reimbursement Studies 
Eltorai et al. (2018) explored trends in Medicare reimbursements for orthopedic 
procedures from 2000 to 2016 and determined that there was a decrease in the 
reimbursements for the procedures but not the implants.  The researchers used the most 
common orthopedic procedures and Medicare fee schedule to compare the data from 
2000 and 2016 while adjusting the 2000 fees to the 2016 dollars (Eltorai et al., 2018).  
Eltorai et al. indicated the limitations to only using Medicare data, because there was no 
access to private commercial carriers.  While Eltorai et al. conducted their study with a 
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theoretical background and timeframe similar to the current study, the specialty and 
geographical region was different.  
Jones, Scott, Anoff, Pierce, and Glasheen (2015) studied the changes in the payer 
mix and physician reimbursement after the Affordable Care Act and Medicaid 
Expansion. They determined there was an increase in visits for Medicaid with a decrease 
in uninsured and commercial visits with a small increase in physician reimbursements.  
Jones et al. noted a major limitation on as single center analysis of data and suggested 
further research for hospital and physician practices in both Medicaid expansion and no 
expansion states on the impact of the ACA and Medicaid expansion on reimbursement 
(Jones et al., 2015).  The changes in reimbursements after major modifications to the 
system needed to be study to determine the effects. 
Riley, Withy, Rogers, DuBose-Morris, and Kurozawa (2017) studied the private 
insurance and Medicare reimbursement rates of CPT code 99213 (Established patient 
level 3 evaluation and management) for the year 2012 using secondary data to compare to 
the cost of living in the area for 490 localities across the United States. Riley et al. found 
that Hawai’i has the lowest physicians’ annual wages in terms of the adjusted cost of 
living and reimbursements for 99213.  Riley et al. indicated limitations of inability to 
compare data from multiple data sources and future research could include researching 
the satisfaction levels of physicians in areas with improved reimbursements. 
Witte, MacPhee, Ginsburg, and Deshmukh (2017) studied Medicaid 
reimbursements from 2004 to 2014 to determine if the Patient Protection and Affordable 
Care Act from 2010 influenced coverage of the female condom. Witte et al. concluded 
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that 26 states reimburse and 14 do not, which constituted a 33% increase from 2007.  The 
study limitations were indicated as data challenges for actual usage data for the states that 
provide reimbursement (Witte et al., 2017). 
Hempstead, Sung, Gray, and Richardson (2015) studied the trends in provider 
reimbursements and patient obligations for Athena health providers between 2013 and 
2014. More than 17 million visits to nearly 15,000 providers resulted in primary care 
payments increased by 3.8% and surgeries decreased 3.7%.  The high out-of-pocket plans 
increased the practices bad debt obligations and further research was needed to monitor 
the changes in reimbursements as insurance companies change their low-income markets 
(Hempstead et al., 2015). 
ICD-10 Implementation 
The ICD-10 implementation delay from October 2014 to 2015 by the Centers for 
Medicare & Medicaid Services cost the healthcare industry was beneficial for providers 
who ignored the change. However, others had invested in the implementation, spent 
considerable amounts in training, and upgraded systems and staff with costs to the 
healthcare industry of approximately $1 billion to $6.6 billion, depending on the practice 
or health system size (Daly, 2014).  Healthcare providers pushed for the delay with the 
support of an American Medical Association-sponsored report finding that 
implementation will be more expensive than previously estimated with costs in the range 
from $56,639 to $226,105 for small practices; $213,364 to $824,735 for medium-sized 
practices; and about $2 million to more than $8 million for large practices. The previous 
estimates were $83,290 for small practices, $285,195 for medium-sized practices and 
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more than $2.7 million for large ones (Robeznieks, 2014).  Many practices exhausted 
their financial resources getting ready for the 2014 deadline that their budgets did not 
allow for additional costs associated with the delay to 2015 (Carney, 2014). 
ICD-10 was an extensive shift in the coding system that affected every aspect of 
healthcare operation (Sanders et al., 2012).  Practices prepared for a contingency plan in 
case the implementation was not smooth and if there was a significant decrease in 
revenue (Spear, 2015).  The transition to ICD-10 was the largest mandate in U.S. 
healthcare history to date and required governance, education, and documentation 
(Goldstein, 2015). 
After the ICD-10 Transition 
The CPT changes as well as the new ICD-10 code-set was challenging for all 
providers regardless if practice or hospital-based in 2015 (Carney, 2014).  Experts 
suggested practices have at least three months cash on hand if claims were slow to 
process after the implementation; with everyone converting at once, there were delays in 
processing (Carney, 2014).  There were also changes in methodologies for payments for 
some providers and facilities, this change required improved documentation by providers 
(Carney, 2014).  Medicare prolonged the specificity of ICD-10 (eg. C81 versus C81.00) 
until October 1, 2016 before rejecting claims for payment; ensuring the correct diagnosis 
and medical necessity were vital when billing (Dowling, 2015).    
The Medical Group Management Association (MGMA) conducted a post-ICD-10 
implementation survey and respondents listed the top 2016 priorities as optimizing 
revenue cycle management, working toward a value-based care model and automating 
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patient collections (Bradley, 2016).  During the postimplementation period, healthcare 
leaders identified and resolved issues as quickly as possible such as claim denials, 
rejections, or coding backlogs to minimize declines in productivity and cash-flow 
(Tennant, 2013). 
Revenue Cycle Management 
Healthcare leaders needed to focus more on revenue cycle management while 
running a very efficient business to maintain profit levels while searching for new 
opportunities to enhance the practice (Rutherford, 2017).  The demands of running a 
successful modern medical practice requires more staff and time than it did five years 
ago, requiring providers to use a successful revenue cycle management process (Bentley 
& Robinson, 2016).  The healthcare revenue cycle includes more than just billing and 
collecting fees; it dealt with every aspect of the patient process and requires 
knowledgeable, efficient, organized, and dedicated administrative staff (Bentley & 
Robinson, 2016).  The Centers for Medicare and Medicaid Services rejects nearly 26% of 
all claims and up to 40% of those claims were never resubmitted, which can account for a 
10% of loss revenues for the practice (Bentley & Robinson, 2016).  A successful revenue 
cycle management system could increase payments and decrease bad debt write-offs 
affecting the practice with revenue cycle optimization by utilizing technology, 
knowledge, and commitment to increase reimbursement from payers and patients in the 
shortest possible time (Bentley & Robinson, 2016).  
 For the implementation of ICD-10, providers needing to educate themselves 
about electronic records, practice management systems, clinical documentation, ICD-10 
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code-set conversion, cash flow and how to research new payment models (Carney, 2014).  
Practice managers reviewed data from the first post transition months to help optimize 
revenue by identifying denial and rejection trends (Bradley, 2016). 
Definitions 
The following terms were defined for the purpose of this study: 
Allowed amount: The amount an insurance plan will pay for a covered health care 
service (HealthCare.gov, n.d.). 
Current procedural terminology (CPT): Current procedural terminology refers to 
codes used to record what procedures were being completed in healthcare.  First 
published in 1966 and were developed, maintained, and copyrighted by the American 
Medical Association (AMA). Thousands of CPT codes were in use, and they were 
updated annually (AMA, 2018). 
Commercial payer: Insurance companies that receive premiums from the patients 
to provide coverage that was provided by private companies, such as United Healthcare, 
Aetna, Cigna, and Blue Cross and Blue Shield (Archer & Marmor, 2012). 
Government payer: Federally or State funded insurance plans for those with low 
income or disabilities, such as Medicare and Medicaid (Archer & Marmor, 2012). 
International Classification of Diseases (ICD): The International Classification of 
Diseases was the standard diagnostic tool for epidemiology, health management, and 
clinical purposes in the United States was established by the World Health Organization 
(WHO) and updated annually (WHO, 2018). 
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International Classification of Diseases, 9th Revision (ICD-9): The 9th revision 
was adopted in United States in 1979. The code set was updated annually.  ICD-9 was 
approximately 17,000 3-4 numeric or alpha-numeric data set (AAPC, 2018a) 
International Classification of Diseases, 10th Revision (ICD-10): International 
Classification of Diseases, 10th Revision, Clinical Modification replaced ICD-9 codes on 
Oct 1, 2015, with 141,000 alpha numeric code set up to 7 characters to include diagnostic 
and in-patient procedural codes. (AAPC, 2018b) 
Intraoperative neurophysiological monitoring: Attempts to minimize neurological 
morbidity during surgical procedures by monitoring changes in brain, spinal cord, and 
peripheral nerve functions (American Society of Neurophysiological Monitoring, 2018). 
Medical coding: Medical coding was the conversion of diagnosis, procedures, 
medical services, and equipment for into universal medical alphanumeric codes for 
claims submission to insurance carriers (AAPC, 2018c). 
Medical billing: Medical billing was submitted with follow-up on claims with 
insurance companies to receive payment for services rendered (AAPC, 2018d). 
Reimbursement: Providers were paid on a “fee-for-service” basis, the insurance 
carriers pays the provider a certain amount based on the service provided and the allowed 
amount (Humana, 2018). 
Revenue cycle: The entire cycle of a patient encounter from scheduling to final 




The believed assumptions of this study, but cannot be demonstrated to be true, 
that were critical to the meaningfulness of this study were that the data collected by the 
two intraoperative neurophysiological monitoring companies was reported precisely and 
correctly.  The data provided from the Medicare fee schedule were not a concern, but if 
the data from intraoperative neurophysiological monitoring companies for the 
commercial data were incorrect, the commercial analysis of the reimbursements would be 
affected.  There was no assumption that the codes were bundled affecting the 
reimbursements.  The change in the Medicare Fee Schedule will be calculated at the 
inflation rate of 1.4% from the year 2014 to 2016 to address assumptions in inflation or 
deflation of pricing. (U.S. Inflation Calculator, 2018). 
Scope and Delimitations 
The scope of the study was to understand the difference between reimbursements 
for intraoperative neurophysiological monitoring after the implementation of ICD-10 in 
Oklahoma and does not include outside of the state.  The specific focus was chosen 
because these changes were key components for healthcare leadership to effectively run a 
practice.  Research was completed on the implementation costs and effects on medical 
practices, but not the aftermath, in specific medical specialties. 
The delimitations of the study is the inability to compare the data of commercial 
reimbursements for other intraoperative neurophysiological monitoring companies in 
Oklahoma, as this was proprietary information.  Potential generalizability will be avoided 
17 
 
as most intraoperative neurophysiological monitoring companies will need this study for 
their survival. 
Significance, Summary, and Conclusions 
The preliminary evidence to justify the study was the lack of previous studies on 
neuromonitoring for ICD-10 conversion, reimbursements, administration, or even 
revenue cycle management; although, there were several studies that focused on the 
clinical aspect.  Research of literature produced a paucity of studies, which provide a 
supporting argument for research in this area.  This study may contribute to the 
intraoperative neurophysiological monitoring leadership practices by providing changes 
in reimbursement to allow management to successfully operate the business.  The 
practical applications for this study will aid in the viability of the small intraoperative 
neurophysiological monitoring companies through sustainability of business and possible 
growth which will lead to positive social change. 
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Section 2: Research Design and Data Collection 
Introduction 
The study may provide an understanding specific for health care leaders regarding 
the changes in reimbursement from following the ICD-10 implementation in 
intraoperative neurophysiological monitoring companies in Oklahoma.  The methods and 
procedures described in this section describe the research including sampling size, 
analysis plan, and threats to validity. 
Research Design and Rationale 
The study variables were intraoperative neurophysiological monitoring CPT 
codes (Figure 1), the reimbursements from Medicare, and other commercial insurance 
companies for those codes.  The quantitative research design was correlational in order to 
study the relationship between the different reimbursement rates on intraoperative 
neurophysiological monitoring CPT codes before and after the implementation of ICD-
10.  The study can be completed with minimal time and resource constraints to interpret 
the relationship between the reimbursements and CPT codes.  Correlational research 
determines the relationship, if any, between two or more variables using statistical data to 
interpret (Creswell, 2009).  In this study I found a relationship between the changes in 
reimbursements related to the implementation of ICD-10 for intraoperative 
neurophysiological monitoring for the state of Oklahoma. 
Methodology 
The methodology for the study included the population, sampling, secondary data 
sets, and variances in reimbursement for the CPT codes used in intraoperative 
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neurophysiological monitoring from 2014 to 2016. The period of the conversion was 
from ICD-9 to ICD-10.  Accounting for the possible yearly inflation allowed in the codes, 
a review of the allowable codes from each year used for comparison regarding what was 
paid and compared to the percentage of Medicare rates. 
Population 
The population for this study includes more than 10,000 CPT codes created and 
maintained by the AMA (2018) and the Centers for Medicare and Medicaid Services Fee 
Schedule. 
Sampling 
The sampling of the population includes 15 intraoperative neurophysiological 
monitoring codes of CPT with and without modifiers with the specific fee schedule for 
the state of Oklahoma from the Centers for Medicare and Medicaid Services Fee 
Schedule for the years 2014 and 2016.  Medicare rates were adjusted based on the 
practice costs to provide the service per area (CMS, 2018).  For example, the cost for 
intraoperative neurophysiological monitoring in New York would be higher than 
Oklahoma due to the cost of living for salaries and insurance.  The codes listed in Table 1 
were the inclusion and the codes that were not related to intraoperative 
neurophysiological monitoring were the exclusion. The fee schedules for states other than 
Oklahoma were also an exclusion.  
The procedures for recruitment, participation, and data collection associated with 
the secondary data set of the Medicare fee schedule was published on their website.  The 
possible commercial insurance reimbursement rates data will be provided by two 
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Oklahoma intraoperative neurophysiological monitoring companies.  Permission to gain 
access to the data of intraoperative neurophysiological monitoring companies’ 
proprietary commercial reimbursements was requested verbally and approved.   
Instruction and Operationalization of Constructs 
The published data sets were the Centers for Medicare and Medicaid Services fee 
schedule for the years 2014 and 2016.  These were appropriate for the current study to 
determine if there were any changes in reimbursements due to the change from ICD-9 to 
ICD-10.  The data was available to the public not requiring specific permissions for use.  
The Centers for Medicare and Medicaid Services fee schedule was a governmental 
published dataset that was reliable, valid, and relevant to every healthcare provide in the 
United States.   
Operationalization 
The variables of intraoperative neurophysiological monitoring CPTs (Figure 1) 
included the description of the code.  Each variable was measured on the geographic 
practice cost index and the relative value units for work, practice expense, and 
malpractice to determine the rate in the Centers for Medicare and Medicaid Services fee 
schedule (CMS, 2018).   An example was that code 95813 was valued at $25.14 for 2014 
in the Centers for Medicare and Medicaid Services fee schedule. 
Data Analysis Plan 
The data analysis plan explained how the data for the study was cleaned, 
transformed, and analyzed.  The cleaning of data removed any univariate outliers, 
missing data, and assess for normality. The variables of the fee schedule were assessed 
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for univariate outliers with a standard deviation of greater than ±3.29 from the variable’s 
mean.   Missing data was addressed by eliminating the observation where possible.   
The software used for the analyses was SPSS® and Microsoft Excel.  The data 
sets were downloaded from the public websites for Medicare, Medicaid, and Workman’s 
Compensation.  The specific data was extracting the specific intraoperative 
neurophysiological monitoring CPT codes from the different fee schedule datasets to 
import into SPSS® for 2014 and 2016.  Manual review and extraction of reimbursements 
for commercial carriers were entered in SPSS® for analysis after data cleaning and 
screening.  The data cleaning and scrubbing will ensure there was no patient identifiers 
available in the data.  The CPT code reimbursements from 2014 will be compared to 
those from 2016 to determine the statistical difference, if any for Medicare and the 
commercial carriers.  This study could be replicated with the Medicare Fee Schedule for 
other states or specialties except for the proprietary commercial reimbursements. 
Research Questions 
The restated research questions and hypotheses as written in Section 1.   
Research Question1: To what extent was the difference, if any, between the 
independent variables of intraoperative neurophysiological monitoring CPT codes and 
dependent continuous variables within the Medicare Fee Schedule for 2014 and 2016 for 
intraoperative neurophysiological monitoring companies in Oklahoma? 
H01: There was not a statistically significant difference on independent variables 
of intraoperative neurophysiological monitoring CPT codes and dependent continuous 
variables of the Medicare Fee Schedule for 2014 and 2016. 
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Ha1: There was a statistically significant difference on independent variables of 
intraoperative neurophysiological monitoring CPT codes and dependent continuous 
variables of the Medicare Fee Schedule for 2014 and 2016. 
Research Question 2: What was the difference between the independent variables 
of intraoperative neurophysiological monitoring CPT codes and the dependent 
continuous variables of the rate paid by commercial carriers for 2014 and 2016 for 
intraoperative neurophysiological monitoring companies in Oklahoma? 
H02: There was not a statistically significant difference between the independent 
variables of intraoperative neurophysiological monitoring CPT codes and dependent 
continuous variables of the rate paid by commercial carriers for 2014 and 2016. 
Ha2: There was a statistically significant difference between the independent 
variables of intraoperative neurophysiological monitoring CPT codes and dependent 
continuous variables of the rate paid by commercial carriers for 2014 and 2016. 
Research Question 3: How did the conversion from ICD-9 to ICD-10 (i.e., 2014 
versus 2016) affect the revenue cycle management for intraoperative neurophysiological 
monitoring companies in Oklahoma? 
H03: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) positively 
affected the revenue cycle management for intraoperative neurophysiological monitoring 
companies in Oklahoma.  
Ha3: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) negatively 
affected the revenue cycle management for intraoperative neurophysiological monitoring 





Sample t tests were used to test the hypotheses above as the variables were 
related.  The CPT code was related to the respected fee schedule amount for that code.  
The variables continuous and will be comparing the means on each CPT code for the 
reimbursements from 2014 and 2016.  Multiple tables will clarify the multiple statistical 
sample t tests for the difference between Medicare and commercial reimbursements for 
the two years.  The study should not have any covariate or cofounding variables due to its 
nature.  The final stage of the analysis plan was the interpretation of the research.  A 
summary of the quantitative data was provided with the statistical information visually 
displayed to increase understanding. 
Threats to Validity 
Due to the nature of the study and use of secondary statistical data, a known threat 
to external, internal, or construct validity would be scrubbing or cleaning of the data.  The 
data were carefully scrubbed and cleaned to ensure no patient identifiers will be 
available.   
Ethical Procedures 
The datasets were from open-sourced peer-reviewed and government sources 
causing no ethical concerns.   The datasets were specifically financial with no human 
participant involvement.  Ethical procedures were taking into consideration to protect 
confidential data to ensure the data was secure with minimal access.  There were no 
ethical concerns related to recruitment materials and processes as described in secondary 
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data set materials.  The use of commercial insurance carrier reimbursement data from 
intraoperative neurophysiological monitoring companies in Oklahoma was proprietary 
and therefore anonymous.  The only ethical concern could possibly be using secondary 
data within the author’s own work environment for the commercial insurance 
reimbursement research question. 
Summary 
The methods and procedures described in this section describe the research 
including sampling size, analysis plan, and threats to validity for the study on the changes 
in reimbursement from following the ICD-10 implementation in intraoperative 
neurophysiological monitoring companies in Oklahoma.  The results and findings of this 
study will be ne interpreted in the results and findings section. 
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Section 3: Presentation of the Results and Findings 
Introduction 
The purpose of this correlational, quantitative study was to provide understanding 
for health care leaders regarding the changes in reimbursement following the ICD-10 
implementation in intraoperative neurophysiological monitoring companies in Oklahoma.  
The overarching research question was as follows: What was the statistical significance, 
if any, between the changes in reimbursements from following the ICD-10 
implementation in intraoperative neurophysiological monitoring companies in 
Oklahoma?  The hypothesis for the research question was that there was a statistical 
significance in the change of reimbursements.  In the following section, I will describe 
the data collection of secondary data sets and the results. 
Data Collection of Secondary Data Sets 
The time frame for data collection was 3 business days as Medicare, Medicaid, 
and Workman’s Compensation data was available from their public websites.  The data 
response rates from all carriers was 100% indication for a confidence interval for the 
study. 
There were no discrepancies in the use of the secondary data set from the plan 
presented in Section 2. The baseline descriptive and demographic characteristics of the 
sample include CPT codes and the appropriate allowed amount per the insurance carrier 
or the reimbursement amount from their fee schedule. The sample of the intraoperative 
neurophysiologic monitoring CPT codes and reimbursements was a representative 
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sample of the population of the over 8,000 total CPT codes.  The sample includes all the 
intraoperative neurophysiologic monitoring CPT codes. 
Results 
The descriptive statistics from the data on the changes in reimbursements for 
intraoperative neurophysiological monitoring are represented in Table 2 per CPT code.  
Due to the type of data studied, standard deviations were high and not consistent.  Data 
on the reimbursements for intraoperative neurophysiological monitoring CPT codes from 
the Oklahoma Workman’s Compensation, and some of the commercial carriers had no 
change in reimbursements from 2014 to 2016.  The lack of change affected the mean, 
median, and mode, adding to the variety of standard deviations in the data. 
Table 2  
Descriptive Statistics 
Code Description Mean Median Mode 
G0453 Remote Intraoperative Monitoring $1.95 $0.15 $0 
95925 Upper SSEP Bilateral $-18.38 $-7.83 $0 
95926 Lower SSEP Bilateral $-18.88 $-3.20 $0 
95938 Upper & Lower SSEP Bilateral $-1.59 $0 $0 
95927 Trunk/Head SSEP Bilateral $-12.03 $-8.86 $0 
95928 TcMEP Upper Limbs $-20.58 $-12.31 $0 
95939 TcMEP Upper & Lower Limbs $-20.05 $-8.71 $0 
95937 NeuroMusclular Junction $-0.51 $0 $0 
95861 EMG Two Extremity  $-2.89 $0 $0 
95870 Trunk/Extremity EMG  $-1.55 $0 $0 
51785 Anal Sphincter $-4.74 $0 $0 
95812 EEG 41-60 minutes $-29.96 $-22.12 $0 




The statistical assumptions appropriate to the study are the scale of measurement, 
simple random sample of the total population, normal distribution, and homogeneity of 
variance.  The statistical analysis findings organized by CPT code and carrier indicated 
that there was an overall decrease in reimbursements among all carriers from 2014 to 
2016, especially when adjusted for the 1.4% inflation rate.  The carriers that did not have 
a change in reimbursements from 2014 to 2016 indicated a 1.4% decrease because of the 
inflation rate.  
Some CPT codes showed an increase but not enough to outweigh the decrease as 
a whole.  When combing all data as a whole, there was an average of 10% decrease in 
reimbursements of the carriers that had a change in reimbursements.  Overall with the 
carriers with no change in reimbursements but adjusted with the 1.4% inflation rate, the 
overall change on reimbursements was -6%.   
The highest percentage of change per procedure code and insurance carrier was 
11% for remote monitoring (G0453) for a commercial carrier and the lowest was -46% 
for lower somatosensory evoked potentials (95926) for Medicaid.  Medicaid had the 
largest change in reimbursements of -18% and the smallest change of Medicare at -6%.  
The changes in reimbursements from 2014 to 2016 are indicated in Table 3.  
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Table 3  
Percentage of Change from 2014 to 2016 
Code Description Medicaid Medicare Commercial 
G0453 Remote Intraoperative Monitoring 11% 1% 19% 
95925 Upper SSEP Bilateral -38% -11% -26% 
95926 Lower SSEP Bilateral -45% -5% -32% 
95938 Upper & Lower SSEP Bilateral -8% 2% 4% 
95927 Trunk/Head SSEP Bilateral -25% -14% -14% 
95928 TcMEP Upper Limbs -26% -12% -15% 
95939 TcMEP Upper & Lower Limbs -12% 2% -2% 
95937 NeuroMusclular Junction -6% -4% 4% 
95861 EMG Two Extremity  -12% 2% -2% 
95870 Trunk/Extremity EMG  -14% 6% -4% 
51785 Anal Sphincter -13% 3% -3% 
95812 EEG 41-60 minutes -20% -23% -9% 
95813 EEG greater than 1 hour -15% -19% -5% 
Averages -18% -6% -7% 
 
 























Figure 2. Percentage of reimbursements change per CPT code. 
 
The intraoperative neurophysiological monitoring procedure with the greatest 
mean annual decreases in reimbursement was the lower Somatosensory Evoked 
Potentials (SSEP) with -28% amongst all carriers.  The intraoperative neurophysiological 
monitoring procedures with the least annual reimbursement decreases were transcranial 
electrical motor potential (TcMEP) monitoring and Electromyography (EMG) with -2% 
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Table 4  
Percentage of Change from 2014 to 2016 Mean 
Code Description Mean 
G0453 Remote Intraoperative Monitoring 11% 
95925 Upper SSEP Bilateral -25% 
95926 Lower SSEP Bilateral -28% 
95938 Upper & Lower SSEP Bilateral -2% 
95927 Trunk/Head SSEP Bilateral -18% 
95928 TcMEP Upper Limbs -18% 
95939 TcMEP Upper & Lower Limbs -4% 
95937 NeuroMusclular Junction -2% 
95861 EMG Two Extremity  -4% 
95870 Trunk/Extremity EMG  -4% 
51785 Anal Sphincter -4% 
95812 EEG 41-60 minutes -17% 
95813 EEG greater than 1 hour -13% 
 
 























G0453 95925 95926 95938 95927 95928 95939 95937 95861 95870 51785 95812 95813
Average Change per CPT Code
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The research questions and hypotheses as written in Section 1 were as follows:   
RQ 1: To what extent was the difference, if any, between the independent 
variables of intraoperative neurophysiological monitoring CPT codes and dependent 
continuous variables within the Medicare Fee Schedule for 2014 and 2016 for 
intraoperative neurophysiological monitoring companies in Oklahoma? 
H01: There was not a statistically significant difference on independent variables 
of intraoperative neurophysiological monitoring CPT codes and dependent 
continuous variables of the Medicare Fee Schedule for 2014 and 2016. 
Ha1: There was a statistically significant difference on independent variables of 
intraoperative neurophysiological monitoring CPT codes and dependent 
continuous variables of the Medicare Fee Schedule for 2014 and 2016. 
Ha1 was the supported hypothesis with a 6 % decrease in Medicare 
reimbursements for intraoperative neurophysiological monitoring CPT codes for 2014 
and 2016. 
RQ 2: What was the difference between the independent variables of 
intraoperative neurophysiological monitoring CPT codes and the dependent continuous 
variables of the rate paid by commercial carriers for 2014 and 2016 for intraoperative 
neurophysiological monitoring companies in Oklahoma? 
H02: There was not a statistically significant difference between the independent 
variables of intraoperative neurophysiological monitoring CPT codes and 




Ha2: There was a statistically significant difference between the independent 
variables of intraoperative neurophysiological monitoring CPT codes and 
dependent continuous variables of the rate paid by commercial carriers for 2014 
and 2016. 
Ha2 was the supported hypothesis with an overall decrease of 3% of 
intraoperative neurophysiological monitoring CPT codes for 2014 and 2016. 
RQ 3: How did the conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) 
affect the revenue cycle management for intraoperative neurophysiological monitoring 
companies in Oklahoma? 
H03: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) positively 
affected the revenue cycle management for intraoperative neurophysiological 
monitoring companies in Oklahoma.  
Ha3: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) negatively 
affected the revenue cycle management for intraoperative neurophysiological 
monitoring companies in Oklahoma. 
Ha3 was the supported hypothesis with an overall decrease in reimbursements of 
6% when including the carriers with no change and a 10% decrease with the carriers that 
had changes in reimbursements. 
Summary 
The methods and procedures described in this section represented the results of 
the study on changes in reimbursements for intraoperative neurophysiological monitoring 
CPT codes for 2014 and 2016.  Ha1 was the supported hypothesis for RQ 1, with a 6% 
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decrease in Medicare reimbursements for intraoperative neurophysiological monitoring 
CPT codes for 2014 and 2016.  Ha2 was the supported hypothesis for RQ 2, with an 
overall decrease of 3% of intraoperative neurophysiological monitoring CPT codes for 
2014 and 2016.  Ha3 was the supported hypothesis for RQ 3, with an overall decrease in 
reimbursements of 6% when including the carriers with no change and a 10% decrease 
with the carriers that had changes in reimbursements.  The findings of the study indicated 
an overall decrease in reimbursements after implementation of ICD-10 for intraoperative 
neurophysiological monitoring. In Section 4, I will present the application for 




Section 4: Application to Professional Practice and Implications for Social Change  
Introduction 
The purpose and nature of this correlational, quantitative study was to provide 
health care leaders with an understanding of the changes in reimbursement following 
ICD-10 implementation in intraoperative neurophysiological monitoring companies in 
Oklahoma.  The findings of the study indicated an overall 6-10% decrease in 
reimbursements for intraoperative neurophysiological monitoring after implementation of 
ICD-10.  
Interpretation of the Findings 
The decrease in reimbursements does not offset the high costs of ICD-10 
implementation.  Healthcare leaders will need to find additional revenue-generating 
options while keeping costs down.  Medicare had an overall decrease of reimbursements 
of 6%, whereas Medicaid had a much larger decrease of 18%.  The results of this study 
are comparable to the study by Eltorai et al. (2018) on orthopedic procedures with a 
decrease in reimbursements.  The continued increase in costs and decrease in 
reimbursements are compounding the challenges for healthcare leaders for cost-effective 
business.  Other revenue-generating options will need to be considered to sustain 
business.  
Limitations of the Study 
There were limitations due to the physician-contracted rates with the payers, as 
some providers could have contracted higher rates than those studied.  Limitations might 
include payer mix variations per carrier.  Participation was limited by geographic location 
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of Oklahoma and did not include outside of the state.  There could be limitations 
pertaining to no control over the providers who participated in the study.  
Recommendations 
 Recommendations for further research, grounded in the strengths and limitations 
of the current study as well as the literature reviewed, would be to research the changes in 
intraoperative neurophysiological monitoring for other states and other specialties.   
Professional Practice 
Recommendations for professional practice include continued monitoring of 
reimbursement changes to ensure the decrease levels out in following years.  If the 
decrease does not level out, renegotiating the commercial carrier contracts will be 
required by healthcare leaders to offset the carriers that have a set fee schedule that is not 
negotiable, such as Medicare and Medicaid.  Contract management will be key to 
maintain reimbursements with the rising costs of business.  Changes in reimbursements 
affect the cash flow of the practice and other operating capital.   
Positive Social Change 
The ICD-10 implementation delay from October 2014 to 2015 by the CMS was 
welcomed by providers that were ignoring the change, not by others that had already 
invested in the implementation, spending considerable amounts in training, upgrading 
systems, and staff with overall costs to the healthcare industry of approximately $1 
billion to $6.6 billion (Daly, 2014).  ICD-10 was an extensive shift in the coding system 
that will affect every aspect of healthcare operation (Sanders et al., 2012).  Healthcare 
leaders need to focus more on revenue cycle management while running a very efficient 
36 
 
business to maintain profit levels while searching for new opportunities to enhance the 
practice (Rutherford, 2017).  These changes affect their livelihood of several small 
intraoperative neurophysiological monitoring companies in Oklahoma.  This study on the 
changes in reimbursement from ICD-9 to ICD-10 assisted healthcare leadership to make 
the necessary changes in business and their revenue cycle management to ensure the 
stability and future of the Oklahoma intraoperative neurophysiological monitoring 
companies. 
Conclusion 
This study evaluated the changes in reimbursements due to the change from ICD-
9 to ICD-10 for intraoperative neurophysiological monitoring in Oklahoma.  The 
transition from ICD-9 to ICD-10 was a massive undertaking by physicians, hospitals, and 
clinics with high costs and without a clear understanding of the future impact.  Healthcare 
leaders can effectively manage their practice and revenue cycle management with the 
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